Continued as
Cancer Epidemiology
Elsevier has purchased Cancer Detection and Prevention from the International Society for Preventive Oncology (ISPO). The first
issue to be published under Elsevier ownership is Volume 32 Issue 3. After much research and careful consideration, we have decided
to expand the scope of ... click here for full Aims & Scope
Elsevier has purchased Cancer Detection and Prevention from the International Society for Preventive Oncology (ISPO). The first
issue to be published under Elsevier ownership is Volume 32 Issue 3. After much research and careful consideration, we have decided
to expand the scope of the journal to encompass cancer epidemiology, in addition to cancer detection and prevention. Therefore, we are
delighted to announce that Cancer Detection and Prevention will be re-launched in 2009 as Cancer Epidemiology: the
international journal of cancer epidemiology, detection and prevention.
Cancer Epidemiology (Cancer Epidemiol.)
will be dedicated to advancing cancer prevention and control. The journal will publish original research articles and review articles
on all aspects on cancer epidemiology, detection and prevention. Cancer Epidemiology will continue to be indexed in PubMed/MEDLINE,
Current Contents/Clinical Medicine, the Science Citation Index Expanded, and the Thomson Reuters Journal Citation Reports, Science Edition
(Impact Factors).
Elsevier would like to take this opportunity to acknowledge the significant and important contribution that ISPO
has made to the scientific and medical community. The Society was founded in 1976 by Professor Herbert E. Nieburgs and a group of associates
to study the interactive etiologic factors in cancer development and their impact on prevention, detection and management of neoplastic
diseases. Cancer Detection and Prevention was established as the official journal of ISPO, publishing original research and
review articles in the field of predictive and preventive oncology. Under the leadership of Professor Nieburgs the journal has become
an international publication with an Impact Factor and coverage in PubMed/Medline and many other indexing and abstracting services.
Elsevier is proud to acknowledge the enormous contribution of Professor Nieburgs and his colleagues. Read
more...
For manuscript and author queries please contact:
Tania Gilligan
Editorial Office
Elsevier
Brookvale
Plaza, East Park
Shannon, Co. Clare
Ireland
Telephone: +353 61 709 674
Fax: +353 61 709 274
Email: cancerepi@elsevier.com
For all other queries please contact:
Sarah Jenkins
Publishing Editor
Elsevier
The Boulevard, Langford Lane
Kidlington,
Oxford OX5 1GB
UK
Telephone: +44 (0) 1865 843243
Fax: +44 (0) 1865 843997
Email: sl.jenkins@elsevier.com
Hide Aims & Scope
Editor-in-Chief: Contact the Editor
J. Schüz
Home | Elsevier Sites | Privacy Policy | Terms and Conditions | Feedback | Site Map | A Reed Elsevier Company